Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date This Week's Must Reads Biologics yield low rates of skin clearance in real-world psoriasis study, AAD-NPF releases first guidelines for nonbiologic treatments of psoriasis, Tildrakizumab Signals Safe for Pregnant Psoriasis Patients, Ixekizumab Favorable for Moderate Psoriasis, How Much Secukinumab Treats Plaque Psoriasis?, Psoriasis Biologics yield low rates of skin clearance in real-world psoriasis study, AAD-NPF releases first guidelines for nonbiologic treatments of psoriasis, Read more in Psoriasis
